Y-mAbs Therapeutics Inc (YMAB)
17.22
-0.02
(-0.12%)
USD |
NASDAQ |
May 07, 16:00
17.22
0.00 (0.00%)
After-Hours: 20:00
Y-mAbs Therapeutics Shareholders Equity (Quarterly): 100.98M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.98M |
| September 30, 2023 | 100.15M |
| June 30, 2023 | 104.68M |
| March 31, 2023 | 107.83M |
| December 31, 2022 | 109.22M |
| September 30, 2022 | 107.90M |
| June 30, 2022 | 131.40M |
| March 31, 2022 | 157.47M |
| December 31, 2021 | 180.11M |
| September 30, 2021 | 210.84M |
| June 30, 2021 | 234.32M |
| March 31, 2021 | 252.22M |
| Date | Value |
|---|---|
| December 31, 2020 | 105.84M |
| September 30, 2020 | 116.51M |
| June 30, 2020 | 146.01M |
| March 31, 2020 | 175.33M |
| December 31, 2019 | 198.90M |
| September 30, 2019 | 85.94M |
| June 30, 2019 | 108.38M |
| March 31, 2019 | 125.51M |
| December 31, 2018 | 140.53M |
| September 30, 2018 | 155.03M |
| June 30, 2018 | 65.52M |
| December 31, 2017 | 82.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
85.94M
Minimum
Sep 2019
252.22M
Maximum
Mar 2021
143.90M
Average
116.51M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
| The Cooper Companies Inc | 7.695B |
| Puma Biotechnology Inc | 50.98M |
| Humacyte Inc | 13.55M |
| Moderna Inc | 12.82B |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.87M |
| Total Liabilities (Quarterly) | 26.88M |
| Current Ratio | 5.520 |